SN-22

SN-22
Clinical data
Other names3-(1-Methyl-4-piperidinyl)indole
Drug classSerotonin receptor modulator
Identifiers
  • 3-(1-methylpiperidin-4-yl)-1H-indole
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H18N2
Molar mass214.312 g·mol−1
3D model (JSmol)
  • CN1CCC(CC1)C2=CNC3=CC=CC=C32
  • InChI=1S/C14H18N2/c1-16-8-6-11(7-9-16)13-10-15-14-5-3-2-4-12(13)14/h2-5,10-11,15H,6-9H2,1H3
  • Key:KYSCKYJNMTUJPA-UHFFFAOYSA-N

SN-22, also known as 3-(1-methyl-4-piperidinyl)indole, is a serotonin receptor modulator of the piperidinylindole group related to the psychedelic drug dimethyltryptamine (DMT). Though it is not technically a tryptamine itself, SN-22 can be regarded as a constrained analogue of DMT.

The drug shows affinity for the serotonin 5-HT1A and 5-HT2A receptors (Ki = 146–514 nM and 19–67 nM, respectively). A deuterated isotopologue of SN-22 is known to be a serotonin 5-HT2A receptor agonist, albeit with lower potency than DMT.

The chemical synthesis of SN-22 has been described. Analogues of SN-22 include MTHPI, RU-24969 (5-MeO-THPI), RU-28253, and MPMI, among others. Derivatives include BRL-54443 (5-hydroxy-SN-22), LY-334370, naratriptan, and sertindole. Many other derivatives of SN-22 are also known, most of which are ligands for serotonin 5-HT1A, 5-HT2A, or 5-HT6 receptors, dopamine D2 receptors, or the serotonin transporter (SERT). Deuterated derivatives of SN-22 have been described as well. SN-22, along with MTHPI, shows some resemblance to MPTP in terms of chemical structure.

SN-22 was first described in the scientific literature by Ethan Will Taylor and colleagues by 1988.

See also